Publication | Closed Access

A phase II study of irinotecan and docetaxel combination chemotherapy for patients with previously treated metastatic or recurrent advanced gastric cancer

Gastrointestinal OncologyMedicinePhase Ii StudyPharmacotherapySurgeryCancer TreatmentDocetaxel Combination ChemotherapyOncologyRadiation Oncology